Skip to main content

Krogulski Kenneth's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Jun 6, 2025

Accession no.
0001628280-25-029856
Filed
Jun 6, 2025
Trade date
May 1-30, 2025
Filing delay
36 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $4.82K. It was filed 36 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krogulski KennethCIK 0001695580Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2025Common StockPPurchaseAcquired+45$4.86+$218.7284,798Direct
May 2, 2025Common StockPPurchaseAcquired+45$4.75+$213.75284,843Direct
May 5, 2025Common StockPPurchaseAcquired+45$4.68+$210.6284,888Direct
May 6, 2025Common StockPPurchaseAcquired+45$4.60+$207284,933Direct
May 7, 2025Common StockPPurchaseAcquired+45$4.71+$211.95284,978Direct
May 8, 2025Common StockPPurchaseAcquired+45$4.50+$202.5285,023Direct
May 9, 2025Common StockPPurchaseAcquired+45$4.78+$215.1285,068Direct
May 12, 2025Common StockPPurchaseAcquired+45$5.25+$236.25285,113Direct
May 13, 2025Common StockPPurchaseAcquired+45$5.67+$255.15285,158Direct
May 14, 2025Common StockPPurchaseAcquired+45$5.68+$255.6285,203Direct
May 15, 2025Common StockPPurchaseAcquired+45$5.20+$234285,248Direct
May 16, 2025Common StockPPurchaseAcquired+45$5.37+$241.65285,293Direct
May 19, 2025Common StockPPurchaseAcquired+45$4.92+$221.4285,338Direct
May 20, 2025Common StockPPurchaseAcquired+45$5.41+$243.45285,383Direct
May 21, 2025Common StockPPurchaseAcquired+45$5.05+$227.25285,428Direct
May 22, 2025Common StockPPurchaseAcquired+45$5.10+$229.5285,473Direct
May 23, 2025Common StockPPurchaseAcquired+45$5.14+$231.3285,518Direct
May 27, 2025Common StockPPurchaseAcquired+45$5.27+$237.15285,563Direct
May 28, 2025Common StockPPurchaseAcquired+45$5.68+$255.6285,608Direct
May 29, 2025Common StockPPurchaseAcquired+45$5.66+$254.7285,653Direct
May 30, 2025Common StockPPurchaseAcquired+45$4.93+$221.85285,698Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)